enGene
Beverly Chase has extensive experience in quality assurance and supplier management within the biopharmaceutical industry. Currently serving as the Director of Supplier Management QA at enGene, Beverly has also held significant roles including Managing Director at Biopharm QA Consulting, Associate Director of External Quality at NGM Bio, Associate Director of Nonclinical Quality at Taysha Gene Therapies, and Director of Quality at Immunovant. Beverly holds a Bachelor's degree in Zoology from North Carolina State University, obtained between August 1981 and May 1985.
This person is not in any offices
enGene
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications